Related Experiment Video
Updated: Mar 25, 2026
07:31
Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
6.3K
Organoids as Models for Neoplastic Transformation.
1Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305;
Annual Review of Pathology
|February 25, 2016
Summary
Organoid cancer models mimic human tumors in 3D, offering advantages over traditional methods. These advanced models aid in discovering cancer drivers and developing new therapies.
Area of Science:
- Oncology
- Biotechnology
- 3D Tissue Engineering
Background:
- Human tumors exhibit complex cellular diversity and interactions.
- Accurate cancer models are crucial for understanding tumor biology and developing treatments.
- Traditional 2D cell lines and in vivo models have limitations in recapitulating tumor complexity.
Purpose of the Study:
- To review the benefits, drawbacks, and recent advances in organotypic cancer models (organoids).
- To highlight the application of organoids in cancer research, including driver discovery, tumor biology studies, and therapeutic development.
Main Methods:
- Discusses the development and characteristics of organotypic cancer models.
- Reviews existing literature on the applications of organoids in cancer research.
- Focuses on the integration of 3D architecture with experimental tractability.
Main Results:
- Organoids combine the 3D architecture of in vivo tissues with the experimental advantages of 2D cell lines.
- These models offer a more accurate representation of tumor heterogeneity and microenvironment.
- Recent advances have expanded their utility in various cancer research applications.
Conclusions:
- Organotypic cancer models represent a significant advancement in cancer research.
- They are valuable tools for discovering novel cancer drivers.
- Organoids facilitate the study of tumor biology and the development of innovative cancer therapies.
